A detailed history of Ray Dalio (Bridgewater Associates, LP) transactions in Integer Holdings Corp stock. As of the latest transaction made, Bridgewater Associates, LP holds 27,315 shares of ITGR stock, worth $3.31 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
27,315
Previous 35,103 22.19%
Holding current value
$3.31 Million
Previous $3.48 Million 8.37%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$96.48 - $116.68 $751,386 - $908,703
-7,788 Reduced 22.19%
27,315 $3.19 Million
Q4 2023

Feb 14, 2024

BUY
$69.42 - $100.2 $1.85 Million - $2.67 Million
26,656 Added 315.57%
35,103 $3.48 Million
Q3 2023

Nov 13, 2023

SELL
$78.43 - $93.24 $2.16 Million - $2.56 Million
-27,507 Reduced 76.51%
8,447 $662,000
Q2 2023

Aug 11, 2023

SELL
$75.44 - $88.64 $324,542 - $381,329
-4,302 Reduced 10.69%
35,954 $3.19 Million
Q1 2023

May 12, 2023

BUY
$65.81 - $78.67 $101,018 - $120,758
1,535 Added 3.96%
40,256 $3.12 Million
Q4 2022

Feb 13, 2023

SELL
$51.11 - $74.32 $678,025 - $985,929
-13,266 Reduced 25.52%
38,721 $2.65 Million
Q3 2022

Nov 10, 2022

SELL
$59.5 - $76.22 $2,737 - $3,506
-46 Reduced 0.09%
51,987 $3.24 Million
Q2 2022

Aug 11, 2022

BUY
$66.92 - $87.38 $318,338 - $415,666
4,757 Added 10.06%
52,033 $3.68 Million
Q1 2022

May 13, 2022

BUY
$76.55 - $85.89 $860,268 - $965,231
11,238 Added 31.18%
47,276 $3.81 Million
Q4 2021

Feb 14, 2022

BUY
$79.74 - $93.39 $397,822 - $465,922
4,989 Added 16.07%
36,038 $3.08 Million
Q3 2021

Nov 12, 2021

SELL
$86.25 - $99.66 $216,056 - $249,648
-2,505 Reduced 7.47%
31,049 $2.77 Million
Q2 2021

Aug 13, 2021

BUY
$85.84 - $95.9 $2.88 Million - $3.22 Million
33,554 New
33,554 $3.16 Million

Others Institutions Holding ITGR

About Integer Holdings Corp


  • Ticker ITGR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,131,000
  • Market Cap $4.02B
  • Description
  • Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through Medical and Non-Medical segments. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional o...
More about ITGR
Track Ray Dalio's Portfolio

Track Ray Dalio Portfolio

Follow Ray Dalio (Bridgewater Associates, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.